Level

AstraZeneca

Senior Director/ Executive Director, Safety Sciences China

AI in this role

At AstraZeneca, we push the boundaries of science to deliver life-changing medicines. Our global Safety Sciences organization delivers innovative non-clinical safety science and toxicology expertise to enable the discovery, development and registration of novel medicines.  

As we expand our footprint in China, we are seeking a senior leader to build and scale local Safety Sciences capabilities and integrate innovation from the local life-science ecosystem.  

This role will lead the Safety Sciences team in China while also providing visible local leadership across the wider Clinical Pharmacology & Safety Sciences (CPSS) organization and ensuring strong alignment with global strategy, priorities, and ways of working. You will lead a high‑performing team, deliver critical toxicology strategies, expertise and data to accelerate global drug discovery and development projects, establish durable partnerships with CROs, top academic institutes, and biotech in China, channel cutting‑edge methods (advanced cell models, NAMs, AI/analytics, omics, Dx safety) to modernize toxicology and enhance translational safety decision‑making. 

Job description 

  • CPSS China leadership: Serve as the China Site Head for CPSS, providing local leadership and coordination across the broader CPSS organization in China. Act as a key link between the China (Shanghai and Beijing) and global CPSS footprints, facilitating alignment of local activities, talent, culture, engagement, and operational priorities with broader strategic objectives. Partner with the CPSS Leadership Team and other senior leaders to strengthen visibility, connectivity, and organizational effectiveness in China. 

  • Deliver effective toxicology strategies for assets developed in China (internally and/or with collaborators), translating program needs into testing strategies, study plans, timelines, and decision-making data, ensuring preclinical safety input that integrates seamlessly into global development and submissions.  

  • Oversee the design, placement, and interpretation of in vitro and in vivo toxicology studies, executed with qualified China CROs – delivering quality, cycle‑time, and cost objectives with clear guardrails. You will ensure scientific integrity, translational context, and proactive risk mitigation; author/review study reports and regulatory modules; and support responses to health authorities, upholding GLP/GxP‑like expectations for data integrity and inspection readiness. 

  • People and matrix leadership: Lead a high performing, bilingual team of Toxicologists, Safety Scientists and Study Monitors. Foster an inclusive culture, leading across cultural boundaries and time zones, setting local objectives aligned with global expertise groups, driving clarity on priorities and accountability. 

  • As a member of the Safety Sciences Leadership Team, contribute to global strategic objectives to Enhance Human Safety Predictions and Accelerate the Delivery of Candidate Drugs to Patients. Serve as the primary Safety Sciences point of contact in the China time zone for cross functional partners, ensuring aligned priorities and seamless integration with global teams. Build credibility and trust with internal governance bodies and external collaborators to accelerate progress. 

  • Innovation and ecosystem development: Anticipate scientific and portfolio trends; scout and pilot China-based innovations (advanced cell models, NAMs, AI/analytics, omics, Discovery safety). Establish collaborations with leading academics, biotech, and preferred CROs, channeling validated approaches into global practice. 

  • Contributes to internal and external scientific reputation and role models demonstration of AZ Values. 

Essential skills and experience 

  • Scientific excellence, with a PhD in toxicology, pharmacology, pathology, cell biology or related life science, with a strong scientific track record, including high impact publications. 

  • Solid drug discovery and development experience from expert/leadership roles in global pharma/biotech (or top‑tier CRO), leading GLP and non‑GLP toxicology packages across the full drug development lifecycle, with strong understanding of multidisciplinary interfaces, such as Clinical, Regulatory and Biology. 

  • People and matrix leadership skills: Demonstrated experience building high performing teams and coaching/mentoring (senior) scientists. Proven ability to lead through a complex global matrix, aligning stakeholders, influencing, resolving trade‑offs, and driving clarity on priorities, accountability, and decision pathways. 

  • Strong awareness of work-related cultural aspects across China, EU, UK, US and a proven ability to work and lead across geographies and cultural barriers, building trust and effective collaboration in a global pharma environment. 

  • Significant expertise in designing and interpreting in vivo toxicology studies, regulatory authorship and interactions, and a strong drive for scientific innovation and investigative toxicology and discovery safety. 

  • Excellent communication and influencing skills, fluent in English and Mandarin, and ability to operate effectively across time zones. 

Desirable 

  • Modality experience across small molecules and large molecules (radioconjugates, antibody–drug conjugates, immune cell engagers). 

  • Experience with private-public collaborations in the China life science innovation ecosystem (CROs, institutes, startups); piloting NAMs/advanced models; digital/AI‑enabled study planning; Dx safety capabilities. 

  • Experience engaging with local Health Authorities (CDE), including preparation of briefing materials, participation in meetings, and follow‑up responses, and familiarity with China early-phase pathways. 

  • Board certification (e.g. DABT) preferred. 

Date Posted

11-8月-2026

Closing Date

AstraZeneca embraces diversity and equality of opportunity.  We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills.  We believe that the more inclusive we are, the better our work will be.  We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics.  We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.

How we score this

Senior Director/ Executive Director, Safety Sciences China at AstraZeneca scores 37 out of 100 for how much of the daily work is AI. That makes it AI Level 1 of 4 (Little AI). The level is about AI in the job, not seniority.

Classification

AI Level 1. The work itself involves no AI, or AI only appears as scenery, such as a company tagline.

  1. AI Level 480 to 100
  2. AI Level 360 to 79
  3. AI Level 240 to 59
  4. AI Level 10 to 39

Bands come from how often the tools, models and workflows of the role are named in the posting itself. Open the description and count.

Get new AI jobs by email

One email a week with the new AI jobs, each rated AI Level 1 to 4 for how much AI is in the work. No recruiter spam, unsubscribe in one click.

Free. One email a week. Unsubscribe in one click.

Similar roles

Other roles rated AI Level 1 at other companies.

What kind of AI work fits you?

Answer 12 practical questions in about three minutes. Get a simple profile, the work it points to, and live roles to explore next.

Find my next step

More jobs at AstraZeneca

Related searches

Same AI level